Kim Popovits

Kim Popovits

Interim Chief Executive Officer
Kim Popovits is the interim CEO of Talis. Prior to this appointment in August 2021, she served on the company’s board of directors since March 2020. Ms. Popovits is the former Chairman of the Board, President and Chief Executive Officer of Genomic Health. Under her leadership Genomic Health became the world’s leading provider of genomic-based diagnostic tests that optimized the treatment of cancer, resulting in an acquisition by Exact Sciences in November 2019. Prior to Genomic Health, Ms. Popovits held several senior management roles at Genentech where she led the commercialization of 14 new therapeutics. Ms. Popovits serves on the boards of 10x Genomics, Kiniksa Pharmaceuticals, Ltd., the Coalition for 21st Century Medicine and the Personalized Medicine Coalition. She also serves as an Executive Advisor to Blackstone Life Sciences and is an Advisor to the Healthcare Businesswomen’s Association (HBA). Ms. Popovits received a B.A. in Business from Michigan State University.